Developments and challenges of FLT3 inhibitors in acute myeloid leukemia by Shuai-Shuai Ge, Shuai-Shuai Ge, Song-Bai Liu, Sheng-Li Xue, Sheng-Li Xue

Get full text

A novel compound heterozygous HAX1 mutation in a Chinese patient with severe congenital neutropenia and chronic myelomonocytic leukemia transformation but without neurodevelopmenta... by Sheng-Li Xue, Jin-Li Li, Jing-Ying Zou, Jian Su, Su-Ning Chen, De-Pei Wu

Get full text

Efficiency of anti‐VEGF therapy in central nervous system AML relapse: A case report and literature review by Han‐Yu Cao, Tao Tao, Xiang‐Dong Shen, Lian Bai, Chao‐Ling Wan, De‐Pei Wu, Jin‐Li Li, Sheng‐Li Xue

Get full text

Phosphoproteomics profiling reveals a kinase network conferring acute myeloid leukaemia intrinsic chemoresistance and indicates HMGA1 phosphorylation as a potential influencer by Yinghui Zhu, Xin He, Shu Li, Yichao Gan, Zheng Li, Hanying Wang, Haojie Dong, Lei Zhang, Sheng‐Li Xue, Yang Xu, Ling Li

Get full text

Patients with CML in the lymphoid blastic phase have inferior response to anti‐CD19 CAR T‐cell therapy compared to de novo Ph‐positive B cell acute lymphoblastic leukemia by Mei‐Jing Liu, Kai‐Wen Tan, Han‐Yu Cao, Si‐Man Huang, Chong‐Sheng Qian, Sheng‐Li Xue, Hai‐Ping Dai, Wen‐Jie Gong

Get full text

Combination of venetoclax with BCR-ABL tyrosine kinase inhibitor as a therapeutic strategy for Philadelphia chromosome-positive leukemias by Jing-Ying Zou, Si-Man Huang, Hai-Xia Zhoub, Ming-Zhu Xu, Ai-Ning Sun, De-Pei Wu, Sheng-Li Xue, Tong-Tong Zhang

Get full text

Case Report: Blinatumomab therapy for the treatment of B-cell acute lymphoblastic leukemia patients with central nervous system infiltration by Han-Yu Cao, Han-Yu Cao, Hui Chen, Song-Bai Liu, Wen-Jie Gong, Wen-Jie Gong, Chong-Sheng Qian, Chong-Sheng Qian, Tong-Tong Zhang, Tong-Tong Zhang, Chao-Ling Wan, Chao-Ling Wan, Si-Man Huang, Si-Man Huang, Nan Xu, Hai-Ping Dai, Hai-Ping Dai, Sheng-Li Xue, Sheng-Li Xue

Get full text

Investigation of the risk factors to predict cytokine release syndrome in relapsed or refractory B-cell acute lymphoblastic leukemia patients receiving IL-6 knocking down anti-CD19... by Wen-Jie Gong, Wen-Jie Gong, Yan Qiu, Yan Qiu, Ming-Hao Li, Ming-Hao Li, Li-Yun Chen, Li-Yun Chen, Yan-Yan Li, Yan-Yan Li, Jing-Qiu Yu, Jing-Qiu Yu, Li-Qing Kang, Ai-Ning Sun, Ai-Ning Sun, De-Pei Wu, De-Pei Wu, Lei Yu, Lei Yu, Sheng-Li Xue, Sheng-Li Xue

Get full text

Successful treatment of acute B lymphoblastic leukemia relapse in the skin and testicle by anti-CD19 CAR-T with IL-6 knocking down: a case report by Ze-Fa Liu, Li-Yun Chen, Jin Wang, Li-qing Kang, Hua Tang, Yao Zhou, Hai-Xia Zhou, Ai-Ning Sun, De-Pei Wu, Sheng-Li Xue

Get full text

Successful application of anti-CD19 CAR-T therapy with IL-6 knocking down to patients with central nervous system B-cell acute lymphocytic leukemia by Li-Yun Chen, Li-Qing Kang, Hai-Xia Zhou, Han-Qing Gao, Xue-Fei Zhu, Nan Xu, Lei Yu, De-Pei Wu, Sheng-Li Xue, Ai-Ning Sun

Get full text

A Combined Histone Deacetylases Targeting Strategy to Overcome Venetoclax Plus Azacitidine Regimen Resistance in Acute Myeloid Leukaemia: Three Case Reports by Bin-Ru Wang, Bin-Ru Wang, Chao-Ling Wan, Chao-Ling Wan, Song-Bai Liu, Qiao-Cheng Qiu, Qiao-Cheng Qiu, Tian-Mei Wu, Tian-Mei Wu, Jun Wang, Jun Wang, Yan-Yan Li, Yan-Yan Li, Shuai-Shuai Ge, Shuai-Shuai Ge, Yan Qiu, Yan Qiu, Xiang-Dong Shen, Xiang-Dong Shen, Sheng-Li Xue, Sheng-Li Xue, Zheng Li, Zheng Li

Get full text

Combination of Venetoclax and Midostaurin Efficiently Suppressed Relapsed t(8;21)Acute Myeloid Leukemia With Mutant KIT After Failure of Venetoclax Plus Azacitidine Treatment by Zheng Li, Zheng Li, Jun Wang, Jun Wang, Shuai-Shuai Ge, Shuai-Shuai Ge, Qiao-Cheng Qiu, Qiao-Cheng Qiu, Jia-Hui Du, Shuang-Shuang Shan, Xiang-Dong Shen, Xiang-Dong Shen, Chao-Ling Wan, Chao-Ling Wan, Bin-Ru Wang, Bin-Ru Wang, De-Pei Wu, De-Pei Wu, Hui-Ying Qiu, Hui-Ying Qiu, Sheng-Li Xue, Sheng-Li Xue

Get full text

Efficacy and safety of cladribine, low-dose cytarabine and venetoclax in relapsed/refractory acute myeloid leukemia: results of a pilot study by Yan-Yan Li, Shuai-Shuai Ge, Yuan-Hong Huang, Ming-Zhu Xu, Chao-Ling Wan, Kai-Wen Tan, Tao Tao, Hai-Xia Zhou, Sheng-Li Xue, Hai-Ping Dai

Get full text

Clonal evolution from B-cell acute lymphoblastic leukemia with <i>BCR::ABL1</i> multilineage involvement to acute myeloid leukemia after multiple anti-CD19 chimeric antigen recepto... by Mei-Jing Liu, Lan Dai, Li Yao, Kai-Wen Tan, Han-Yu Cao, Si-Man Huang, Chao-Ling Wan, Yuan-Hong Huang, Yang Zhang, Wen-Jie Gong, Sheng-Li Xue

Get full text

Preemptive inotuzumab ozogamicin eradicated measurable residual disease in Ph‐negative acute lymphoblastic leukemia relapsed post CD19 CART therapy by Si‐Man Huang, Chao‐Ling Wan, Han‐Yu Cao, Yan‐Yan Li, Chong‐Sheng Qian, Hai‐Xia Zhou, Ming‐Zhu Xu, Xiao‐Hui Hu, Lan Dai, Hai‐Ping Dai, Sheng‐Li Xue

Get full text

Safety and efficacy of CD22 and CD19 CAR-T bridging auto-HSCT as consolidation therapy for AYA and adult B-ALL by Yan Qiu, Chao-Ling Wan, Ming-Zhu Xu, Hai-Xia Zhou, Mei-Jing Liu, Wen-Jie Gong, Li-Qing Kang, Ai-Ning Sun, Lei Yu, De-Pei Wu, Chong-Sheng Qian, Sheng-Li Xue

Get full text

Venetoclax plus hypomethylating agents in newly diagnosed acute myeloid leukemia patients with RUNX1::RUNX1T1: a retrospective propensity score matching study by Miao Wang, Han-Yu Cao, Kai-Wen Tan, Qiao-Cheng Qiu, Yuan-Hong Huang, Shuai-shuai Ge, Zi-Hao Wang, Jia Chen, Xiao-Wen Tang, De-Pei Wu, Sheng-Li Xue, Zheng Li, Hai-Ping Dai

Get full text

Flumatinib plus venetoclax as an effective therapy for Philadelphia chromosome‐positive acute myeloid leukemia: A case report by Si‐Man Huang, Tao Tao, Chao‐Ling Wan, Tian‐Mei Wu, Han‐Yu Cao, Yan Qiu, Xiang‐Dong Shen, Bin‐Ru Wang, Shuai‐Shuai Ge, Yan‐Yan Li, Tong‐Tong Zhang, Bing Wu, Sheng‐Li Xue

Get full text

A Phase II Trial of the Double Epigenetic Priming Regimen Including Chidamide and Decitabine for Relapsed/Refractory Acute Myeloid Leukemia by Jia Yin, Jia Yin, Chao-Ling Wan, Chao-Ling Wan, Ling Zhang, Ling Zhang, Hao Zhang, Lian Bai, Hai-Xia Zhou, Hai-Xia Zhou, Ming-Zhu Xu, Ming-Zhu Xu, Li-Yun Chen, Li-Yun Chen, Chong-Sheng Qian, Chong-Sheng Qian, Hui-Ying Qiu, Hui-Ying Qiu, Su-Ning Chen, Su-Ning Chen, Xiao-Wen Tang, Xiao-Wen Tang, De-Pei Wu, De-Pei Wu, Yan-Ming Zhang, Ai-Ning Sun, Ai-Ning Sun, Sheng-Li Xue, Sheng-Li Xue

Get full text

The differential effects of tumor burdens on predicting the net benefits of ssCART-19 cell treatment on r/r B-ALL patients by Minghao Li, Sheng-Li Xue, Xiaowen Tang, Jiayu Xu, Suning Chen, Yue Han, Huiying Qiu, Miao Miao, Nan Xu, Jingwen Tan, Liqing Kang, Zhou Yu, Xiaoyan Lou, Yang Xu, Jia Chen, Zhiqiang Yan, Weixing Feng, Depei Wu, Lei Yu

Get full text